Celon Pharma SA (CLN) Stock Price & News

CLN:WSE

Celon Pharma SA

PLN 16.00

-1.84%

(-0.30) 1D

Nov 12, 5:02:30 PM GMT+1 · PLN

All symbols

	Symbol	Price	Change	% Change

Next call in 5 days

Wed, Nov 18, 6:35 AM

Fiscal period

Q3 2026

- / -

Revenue / Est. (PLN)

- / 63.50M

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in PLN

Loading Previous Earnings...

All values in PLN	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	71.13M	66.67M	65.26M	55.57M
Cost of goods sold	16.83M	11.54M	16.70M	14.92M
Cost of revenue	16.83M	11.54M	16.70M	14.92M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	33.02M	35.44M	36.08M	38.62M
Operating expense	46.24M	52.60M	54.54M	50.11M
Total operating expenses	63.07M	64.14M	71.23M	65.04M
Operating income	8.06M	2.53M	-5.98M	-9.46M
Other non operating income	-30.00K	-250.00K	169.05M	3.48M
EBT including unusual items	-2.77M	-6.57M	160.34M	-7.38M
EBT excluding unusual items	-2.77M	-6.57M	160.34M	-7.38M
Income tax expense	-6.43M	18.33M	1.70M	23.21M
Effective tax rate	232.29%	-279.14%	1.06%	-314.48%
Other operating expenses	2.20M	6.37M	7.33M	1.36M
Net income	3.66M	-24.90M	158.64M	-30.59M
Net profit margin	5.15%	-37.35%	243.09%	-55.05%
Earnings per share	-	-	-	-
Interest and investment income	-	149.00K	151.00K	151.00K
Interest expense	-	-341.00K	-915.00K	-1.55M
Net interest expenses	-	-192.00K	-764.00K	-1.40M
Depreciation and amortization charges	11.01M	10.78M	11.13M	10.13M
EBITDA	16.34M	11.40M	3.44M	-748.00K
Gain or loss from assets sale	-170.00K	-2.91M	-569.00K	716.00K

Finance